• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有古德综合征的患者及13名患有常见可变免疫缺陷的患者感染新型冠状病毒肺炎的情况。

COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency.

作者信息

Lindahl Hannes, Smith C I Edvard, Bergman Peter

机构信息

Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.

Immunodeficiency Unit, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Clin Immunol Commun. 2021 Dec;1:20-24. doi: 10.1016/j.clicom.2021.08.003. Epub 2021 Oct 8.

DOI:10.1016/j.clicom.2021.08.003
PMID:38620775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8497938/
Abstract

Antibody deficiencies constitute the majority of primary immunodeficiencies in adults. These patients have a well-established increased risk of bacterial infections but there is a lack of knowledge regarding the relative risks upon contracting COVID-19. In this monocentric study the disease course of COVID-19 in 1 patient with Good's syndrome and in 13 patients with common variable immunodeficiency (CVID) is described. The severity of disease ranged from very mild to severe. Several patients required hospitalization and immunomodulatory treatment but all survived. Although viral infections are not a typical feature of humoral immunodeficiencies we recommend that vigilance is increased in the management of patients with Good's syndrome and CVID during the COVID-19 pandemic.

摘要

抗体缺陷是成人原发性免疫缺陷的主要类型。这些患者发生细菌感染的风险已明确增加,但对于感染新型冠状病毒肺炎(COVID-19)后的相对风险尚缺乏了解。在这项单中心研究中,描述了1例Good综合征患者和13例常见变异型免疫缺陷(CVID)患者的COVID-19病程。疾病严重程度从非常轻微到严重不等。数名患者需要住院治疗和免疫调节治疗,但均存活。尽管病毒感染并非体液免疫缺陷的典型特征,但我们建议在COVID-19大流行期间,对Good综合征和CVID患者的管理应提高警惕。

相似文献

1
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency.一名患有古德综合征的患者及13名患有常见可变免疫缺陷的患者感染新型冠状病毒肺炎的情况。
Clin Immunol Commun. 2021 Dec;1:20-24. doi: 10.1016/j.clicom.2021.08.003. Epub 2021 Oct 8.
2
A Bad Case of Good's Syndrome.Good 综合征的不良病例。
Infect Dis Ther. 2014 Dec;3(2):333-7. doi: 10.1007/s40121-014-0045-7. Epub 2014 Oct 7.
3
A Case of Severe COVID-19 in a Patient with Good's Syndrome.一例患有古德综合征患者的重症新型冠状病毒肺炎病例。
Eur J Case Rep Intern Med. 2021 Oct 29;8(10):002976. doi: 10.12890/2021_002976. eCollection 2021.
4
Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.Good 综合征、CVID 和慢性鼻-鼻窦炎患者的选择性抗体缺陷。
Curr Allergy Asthma Rep. 2014 Jun;14(6):438. doi: 10.1007/s11882-014-0438-4.
5
COVID-19 and Good's Syndrome After Thymectomy.胸腺切除术后的新型冠状病毒肺炎与古德综合征
Cureus. 2024 Sep 26;16(9):e70274. doi: 10.7759/cureus.70274. eCollection 2024 Sep.
6
[COVID-19 in adults with antibody deficiencies].[抗体缺乏的成人中的新型冠状病毒肺炎]
Medicina (B Aires). 2021;81(3):478-481.
7
Gastrointestinal pathology in Good's syndrome, thinking beyond common variable immunodeficiency: a clinicopathological observation.古德综合征中的胃肠道病理学:超越常见可变免疫缺陷的思考——一项临床病理观察
Virchows Arch. 2025 Mar 26. doi: 10.1007/s00428-025-04069-7.
8
[Patient with Good's syndrome and COVID-19. Report of a clinical case].[患有古德综合征和新冠病毒病的患者。一例临床病例报告]
Rev Med Inst Mex Seguro Soc. 2022 Jul 4;60(4):474-479.
9
Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review.新冠后遗症导致古德综合征的诊断:一例临床病例报告及文献综述
Clin Case Rep. 2024 May 27;12(6):e8962. doi: 10.1002/ccr3.8962. eCollection 2024 Jun.
10
Case report and literature review on Good's syndrome, a form of acquired immunodeficiency associated with thymomas.关于古德综合征(一种与胸腺瘤相关的获得性免疫缺陷形式)的病例报告及文献综述。
Hawaii J Med Public Health. 2013 Feb;72(2):56-62.

引用本文的文献

1
Missed and misdiagnosis of immunodeficiency: Good syndrome presenting as persistent COVID-19 shedding.免疫缺陷的漏诊和误诊:以持续性新冠病毒脱落为表现的古德综合征
Asia Pac Allergy. 2025 Sep;15(3):235-237. doi: 10.5415/apallergy.0000000000000171. Epub 2025 Jan 8.
2
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.人类中和 I 型干扰素的自身抗体:1981 年至 2023 年。
Immunol Rev. 2024 Mar;322(1):98-112. doi: 10.1111/imr.13304. Epub 2024 Jan 9.
3
Good's syndrome and COVID-19: case report and literature review.古德综合征与新型冠状病毒肺炎:病例报告及文献综述
Mediastinum. 2022 Sep 9;7:5. doi: 10.21037/med-22-12. eCollection 2023.
4
[Patient with Good's syndrome and COVID-19. Report of a clinical case].[患有古德综合征和新冠病毒病的患者。一例临床病例报告]
Rev Med Inst Mex Seguro Soc. 2022 Jul 4;60(4):474-479.
5
Elevated CD21 B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency.CD21+B细胞频率升高是常见可变免疫缺陷患者对辉瑞-生物科技公司的BNT162b2 mRNA新冠疫苗免疫反应不佳的一个标志。
J Clin Immunol. 2022 May;42(4):716-727. doi: 10.1007/s10875-022-01244-2. Epub 2022 Mar 15.

本文引用的文献

1
Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.患有古德综合征的重症新型冠状病毒肺炎患者预后良好。
Clin Immunol. 2022 Feb;235:108789. doi: 10.1016/j.clim.2021.108789. Epub 2021 Jun 29.
2
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
3
HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.补体缺陷患者中存在与 HCoV 和 SARS-CoV-2 发生交叉反应的 T 细胞。
Front Immunol. 2020 Dec 23;11:607918. doi: 10.3389/fimmu.2020.607918. eCollection 2020.
4
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.早期高滴度血浆疗法预防老年人重症 COVID-19。
N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.
5
COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.原发性和继发性免疫缺陷患者的 COVID-19:英国的经验。
J Allergy Clin Immunol. 2021 Mar;147(3):870-875.e1. doi: 10.1016/j.jaci.2020.12.620. Epub 2020 Dec 15.
6
Fatal SARS-CoV-2 infection in a male patient with Good's syndrome.男性 Good 综合征患者的致死性严重急性呼吸综合征冠状病毒 2 感染。
Clin Immunol. 2021 Feb;223:108644. doi: 10.1016/j.clim.2020.108644. Epub 2020 Dec 8.
7
COVID-19 infection in 10 common variable immunodeficiency patients in New York City.纽约市10例常见可变免疫缺陷患者的新冠病毒感染情况。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):504-507.e1. doi: 10.1016/j.jaip.2020.11.006. Epub 2020 Nov 18.
8
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.先天性免疫缺陷患者的 2019 年冠状病毒病:一项国际研究。
J Allergy Clin Immunol. 2021 Feb;147(2):520-531. doi: 10.1016/j.jaci.2020.09.010. Epub 2020 Sep 24.
9
The COVID-19 pandemic and human fertility.新冠疫情与人类生育能力。
Science. 2020 Jul 24;369(6502):370-371. doi: 10.1126/science.abc9520.
10
Precursor B-cell development in bone marrow of Good syndrome patients.Good 综合征患者骨髓中前 B 细胞的发育。
Clin Immunol. 2019 Mar;200:39-42. doi: 10.1016/j.clim.2018.11.009. Epub 2019 Jan 25.